Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun;39(3):272-278.
doi: 10.1111/ijlh.12620. Epub 2017 Apr 26.

Hematologic, hepatic, and renal function changes in hospitalized patients with Middle East respiratory syndrome coronavirus

J A Al-Tawfiq  1   2 , K Hinedi  1 , S Abbasi  1 , M Babiker  1 , A Sunji  1 , M Eltigani  1
Affiliations

Hematologic, hepatic, and renal function changes in hospitalized patients with Middle East respiratory syndrome coronavirus

J A Al-Tawfiq et al. Int J Lab Hematol. 2017 Jun.

Abstract

Background: There are no longitudinal data on the changes in hematologic, hepatic, and renal function findings in patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection.

Methods: This is a retrospective cohort study of 16 MERS-CoV patients, to describe the hematological, hepatic, and renal findings of patients with MERS-CoV.

Results: During the 21 days of observation, there was no significant change in the hepatic panel or creatinine tests. There was a significant increase in the mean ± SD of the white blood cell count from 8.3 ± 4.6 to 14.53 ± 7 (P value = 0.001) and an increase in mean ± SD of the absolute neutrophil count from 6.33 ± 4.2 to 12 ± 5.5 (P value = 0.015). Leukocytosis was observed in 31% (5/16) of the patients on day 1 and in 80% (4/5) on day 21. Transient leukopenia developed in 6% (1/16) of the patients on day 1 and in 13% (1/8) on day 8. None of the patients had neutropenia. Lymphopenia was a prominent feature with a rate of 44% (7/16) of the patients on day 1 and 60% (3/5) on day 21. Lymphocytosis was not a feature of MERS-CoV infection. Thrombocytopenia developed in 31% (5/16) of the patients on day 1 and 40% (2/5) on day 21. Thrombocytosis was not a prominent feature and was observed in 6% (1/16) of the patients on day 1 and 17% (1/6) on day 9.

Conclusions: Patients with MERS-CoV infection showed variable hematologic parameters over time. Lymphocytosis and neutropenia were not features of MERS-CoV infection.

Keywords: Middle East respiratory syndrome; biochemical characteristics; hematologic changes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
An error bar indicating the mean ± standard deviation of daily white blood cell count (×109/L). [Colour figure can be viewed at http://wileyonlinelibrary.com].
Figure 2
Figure 2
An error bar indicating the mean ± standard deviation indicating daily absolute neutrophil (PMN) count (×109/L). [Colour figure can be viewed at http://wileyonlinelibrary.com].
Figure 3
Figure 3
An error bar indicating the mean ± standard deviation indicating daily absolute lymphocyte count (×109/L). [Colour figure can be viewed at http://wileyonlinelibrary.com].
Figure 4
Figure 4
An error bar indicating the mean ± standard deviation indicating daily platelet count (×109/L). [Colour figure can be viewed at http://wileyonlinelibrary.com].
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367:1814–20. - PubMed
    1. World Health Organization . Middle East respiratory syndrome coronavirus (MERS‐CoV) ‐ Saudi Arabia. Disease outbreak news, 6 July 2016. Available at: http://www.who.int/csr/don/06-july-2016-mers-saudiarabia/en/. Accessed October 10, 2016.
    1. Al‐Tawfiq JA, Memish ZA. Middle East respiratory syndrome coronavirus: transmission and phylogenetic evolution. Trends Microbiol 2014;22:573–9. - PMC - PubMed
    1. Al‐Tawfiq JA, Hinedi K, Ghandour J, Khairalla H, Musleh S, Ujayli A, Memish ZA. Middle East Respiratory Syndrome‐Coronavirus (MERS‐CoV): a case–control study of hospitalized patients. Clin Infect Dis 2014;59:160–5. - PMC - PubMed
    1. Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, Hawa H, Alothman A, Khaldi A, Al Raiy B. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 2014;160:389–97. - PubMed

LinkOut - more resources